A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)

What is the purpose of this trial?

The purpose of this study is to determine whether Nivolumab in combination with other therapies is more effective than Nivolumab in combination with Ipilimumab in treating patients/subjects with advanced gastric cancer.



Bristol-Myers Squibb Research and Development

Start Date: 10/09/2017

End Date: 11/30/2021

Last Updated: 03/07/2018

Study HIC#: 2000020656